
Mesa Laboratories Inc
NASDAQ:MLAB

Mesa Laboratories Inc
Revenue
Mesa Laboratories Inc
Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
---|---|---|---|---|---|---|
![]() |
Mesa Laboratories Inc
NASDAQ:MLAB
|
Revenue
$237.7m
|
CAGR 3-Years
13%
|
CAGR 5-Years
17%
|
CAGR 10-Years
13%
|
|
![]() |
Becton Dickinson and Co
NYSE:BDX
|
Revenue
$20.6B
|
CAGR 3-Years
4%
|
CAGR 5-Years
4%
|
CAGR 10-Years
9%
|
|
![]() |
Boston Scientific Corp
NYSE:BSX
|
Revenue
$17.6B
|
CAGR 3-Years
13%
|
CAGR 5-Years
10%
|
CAGR 10-Years
9%
|
|
![]() |
Stryker Corp
NYSE:SYK
|
Revenue
$22.6B
|
CAGR 3-Years
10%
|
CAGR 5-Years
9%
|
CAGR 10-Years
9%
|
|
![]() |
Abbott Laboratories
NYSE:ABT
|
Revenue
$42.3B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
6%
|
CAGR 10-Years
8%
|
|
![]() |
Intuitive Surgical Inc
NASDAQ:ISRG
|
Revenue
$8.7B
|
CAGR 3-Years
14%
|
CAGR 5-Years
14%
|
CAGR 10-Years
15%
|
Mesa Laboratories Inc
Revenue Breakdown
Breakdown by Geography
Mesa Laboratories Inc
Total Revenue:
216.2m
USD
|
United States:
106.4m
USD
|
Other:
84.9m
USD
|
China:
24.9m
USD
|
Breakdown by Segments
Mesa Laboratories Inc
Total Revenue:
216.2m
USD
|
Product:
176.8m
USD
|
Consumables:
121m
USD
|
Hardware And Software:
55.8m
USD
|
Mesa Laboratories Inc
Glance View
Mesa Laboratories, Inc. engages in the design, manufacture, and market of instruments and disposable products utilized in healthcare, pharmaceutical, food and beverage, medical device, and petrochemical industries. The company is headquartered in Lakewood, Colorado and currently employs 506 full-time employees. The firm operates through four segments, Sterilization and Disinfection Control, Biopharmaceutical Development, Instruments, and Continuous Monitoring. The Sterilization and Disinfection Control segment manufactures and sells biological, cleaning, and chemical indicators which are used to assess the effectiveness of sterilization and disinfection processes in the hospital, medical device, and pharmaceutical industries. The Biopharmaceutical Development segment develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. The Instruments segment designs, manufactures, and markets quality control hardware and disposable products. The Continuous Monitoring segment develops, and markets systems which are used to monitor various environmental parameters such as temperature, humidity, and differential pressure.

See Also
What is Mesa Laboratories Inc's Revenue?
Revenue
237.7m
USD
Based on the financial report for Dec 31, 2024, Mesa Laboratories Inc's Revenue amounts to 237.7m USD.
What is Mesa Laboratories Inc's Revenue growth rate?
Revenue CAGR 10Y
13%
Over the last year, the Revenue growth was 12%. The average annual Revenue growth rates for Mesa Laboratories Inc have been 13% over the past three years , 17% over the past five years , and 13% over the past ten years .